BAX Long Call Strategy
BAX (Baxter International Inc.), in the Healthcare sector, (Medical - Instruments & Supplies industry), listed on NYSE.
Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company offers peritoneal dialysis and hemodialysis, and additional dialysis therapies and services; intravenous therapies, infusion pumps, administration sets, and drug reconstitution devices; remixed and oncology drug platforms, inhaled anesthesia and critical care products and pharmacy compounding services; parenteral nutrition therapies and related products; biological products and medical devices used in surgical procedures for hemostasis, tissue sealing and adhesion prevention; and continuous renal replacement therapies and other organ support therapies focused in the intensive care unit. It also provides connected care solutions, including devices, software, communications, and integration technologies; integrated patient monitoring and diagnostic technologies to help diagnose, treat, and manage a various illness and diseases, including respiratory therapy, cardiology, vision screening, and physical assessment; surgical video technologies, tables, lights, pendants, precision positioning devices and other accessories. In addition, the company offers contracted services to various pharmaceutical and biopharmaceutical companies. Its products are used in hospitals, kidney dialysis centers, nursing homes, rehabilitation centers, doctors' offices, and patients at home under physician supervision. The company sells its products through direct sales force, as well as through independent distributors, drug wholesalers, and specialty pharmacy or other alternate site providers in approximately 100 countries.
BAX (Baxter International Inc.) trades in the Healthcare sector, specifically Medical - Instruments & Supplies, with a market capitalization of approximately $8.94B, a beta of 0.62 versus the broader market, a 52-week range of 15.73-32.04, average daily share volume of 9.1M, a public-listing history dating back to 1981, approximately 38K full-time employees. These structural characteristics shape how BAX stock options price implied volatility around earnings windows, capital events, and macro-driven sector rotations.
A beta of 0.62 indicates BAX has historically moved less than the broader market, dampening realized volatility and producing tighter expected-move bands per unit of dollar exposure. BAX pays a dividend, which adjusts put-call parity and shifts the ex-dividend pricing across the listed chain.
What is a long call on BAX?
A long call buys upside exposure with a fixed maximum loss equal to the premium paid; profit accrues if the underlying closes above the strike plus premium at expiration.
Current BAX snapshot
As of May 15, 2026, spot at $17.30, ATM IV 43.85%, IV rank 40.58%, expected move 12.57%. The long call on BAX below is built from the same end-of-day chain, with strikes snapped to listed contracts and premiums pulled from the bid/ask midpoint at a 28-day expiry.
Why this long call structure on BAX specifically: BAX IV at 43.85% is mid-range versus its 1-year history, so strategy selection should anchor more to the directional thesis than to the IV regime, with a market-implied 1-standard-deviation move of approximately 12.57% (roughly $2.17 on the underlying). The 28-day window matched to the front-month expiry keeps theta exposure bounded while still capturing the post-snapshot move; longer-dated BAX expiries trade a higher absolute premium for lower per-day decay. Position sizing on BAX should anchor to the underlying notional of $17.30 per share and to the trader's directional view on BAX stock.
BAX long call setup
The BAX long call below is built from the end-of-day chain, with each option leg priced at the bid/ask midpoint of its listed strike. With BAX near $17.30, the first option leg uses a $17.50 strike; additional legs (when the strategy has them) anchor to spot-relative offsets. Premiums come from the bid/ask midpoint on the listed BAX chain at a 28-day expiry; the cross-strike IV skew is reflected directly in the per-leg values rather than approximated. Quantity sizing assumes one contract per option leg (or 100 BAX shares for the stock leg in covered calls and collars).
| Action | Type | Strike / Basis | Premium (est) |
|---|---|---|---|
| Buy 1 | Call | $17.50 | $0.80 |
BAX long call risk and reward
- Net Premium / Debit
- -$80.00
- Max Profit (per contract)
- Unbounded
- Max Loss (per contract)
- -$80.00
- Breakeven(s)
- $18.30
- Risk / Reward Ratio
- Unbounded
Max profit is unbounded; max loss equals the premium paid times 100. Breakeven is strike plus premium.
BAX long call payoff curve
Modeled P&L at expiration across a range of underlying prices for the long call on BAX. Each row is one sampled price point from the computed payoff curve; the full curve uses 200 price points internally before being summarized into 10 rows here.
| Underlying Price | % From Spot | P&L at Expiration |
|---|---|---|
| $0.01 | -99.9% | -$80.00 |
| $3.83 | -77.8% | -$80.00 |
| $7.66 | -55.7% | -$80.00 |
| $11.48 | -33.6% | -$80.00 |
| $15.31 | -11.5% | -$80.00 |
| $19.13 | +10.6% | +$83.01 |
| $22.95 | +32.7% | +$465.41 |
| $26.78 | +54.8% | +$847.81 |
| $30.60 | +76.9% | +$1,230.22 |
| $34.43 | +99.0% | +$1,612.62 |
When traders use long call on BAX
Long calls on BAX express a bullish thesis with defined risk; traders use them ahead of BAX catalysts (earnings, product launches, macro events) when the expected upside justifies the premium and theta decay.
BAX thesis for this long call
The market-implied 1-standard-deviation range for BAX extends from approximately $15.13 on the downside to $19.47 on the upside. A BAX long call expresses a directional view that the underlying closes above the strike plus premium at expiration, ideally with implied volatility holding or expanding to preserve extrinsic value through the hold period. Current BAX IV rank near 40.58% is mid-range against its 1-year distribution, so the IV signal is neutral; the long call thesis on BAX should anchor more to the directional view and the expected-move geometry. As a Healthcare name, BAX options can move on sector-level news flow (peer earnings, regulatory updates, industry-specific macro data) in addition to BAX-specific events.
BAX long call positions are structurally bullish; the modeled P&L assumes European-style exercise at expiration and ignores early assignment, transaction costs, dividends paid before expiry on the stock leg (when present), and the bid-ask spread on the listed chain. BAX positions also carry Healthcare sector concentration risk; news flow inside the sector (peer earnings, regulatory shifts, supply-chain headlines) can move BAX alongside the broader basket even when BAX-specific fundamentals are unchanged. Long-premium structures like a long call on BAX are particularly exposed to IV-crush risk through scheduled events (earnings, FDA decisions, central-bank meetings) where IV typically contracts post-event regardless of the directional outcome. Always rebuild the position from current BAX chain quotes before placing a trade.
Frequently asked questions
- What is a long call on BAX?
- A long call on BAX is the long call strategy applied to BAX (stock). The strategy is structurally bullish: A long call buys upside exposure with a fixed maximum loss equal to the premium paid; profit accrues if the underlying closes above the strike plus premium at expiration. With BAX stock trading near $17.30, the strikes shown on this page are snapped to the nearest listed BAX chain strike and the premiums come straight from the end-of-day bid/ask midpoint.
- How are BAX long call max profit and max loss calculated?
- Max profit is unbounded; max loss equals the premium paid times 100. Breakeven is strike plus premium. For the BAX long call priced from the end-of-day chain at a 30-day expiry (ATM IV 43.85%), the computed maximum profit is unbounded per contract and the computed maximum loss is -$80.00 per contract. Live intraday quotes will differ as the chain moves through the trading session.
- What is the breakeven for a BAX long call?
- The breakeven for the BAX long call priced on this page is roughly $18.30 at expiration, derived from end-of-day chain premiums. Breakeven is the underlying price at which the strategy's P&L crosses zero ignoring transaction costs and assignment risk. The current BAX market-implied 1-standard-deviation expected move is approximately 12.57%; if the move sits well outside the breakeven distance, the structure's risk-reward becomes correspondingly tighter.
- When should you consider a long call on BAX?
- Long calls on BAX express a bullish thesis with defined risk; traders use them ahead of BAX catalysts (earnings, product launches, macro events) when the expected upside justifies the premium and theta decay.
- How does current BAX implied volatility affect this long call?
- BAX ATM IV is at 43.85% with IV rank near 40.58%, which is mid-range against its 1-year history. Strategy selection depends more on directional thesis and expected move than on a strong IV signal.